Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Healthy Returns

Recent news which mentions Healthy Returns

Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Tags Biotech and Pharmaceuticals Social issues LILLY DRN
From CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
Tags Biotech and Pharmaceuticals Social issues AstraZeneca PLC
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Novo Nordisk A/S Social issues Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Biotech and Pharmaceuticals Social issues UnitedHealth Group Inc
From CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Microsoft Corp Health & Science Healthy Returns
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Social issues LILLY DRN Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
Tags Hims & Hers Health Inc Healthy Returns Health care industry
From CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Tags Hacking Vertex Pharmaceuticals Inc Pfizer Inc
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Health care industry Astellas Pharma Inc Healthy Returns
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Roche Holding AG Health & Science Healthy Returns
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Eli Lilly and Co Novo Nordisk A/S Apple Inc
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Berkshire Hathaway Inc Biotech and Pharmaceuticals Social issues
From CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
Tags Healthy Returns Health care industry Dexcom Inc
From CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
Tags Biotech and Pharmaceuticals Pfizer Inc Social issues
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Biotech and Pharmaceuticals Eli Lilly and Co Health & Science
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Abbvie Inc Health & Science Breaking News: Politics
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Biotech and Pharmaceuticals Eli Lilly and Co Altimmune Inc
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Bristol/Myers Squibb Co Health & Science AstraZeneca PLC
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Healthy Returns Health care industry Health & Science
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Health & Science Eli Lilly and Co Health care industry
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Novo Nordisk A/S Eli Lilly and Co CVS Health Corp
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Biotech and Pharmaceuticals Science Altimmune Inc
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Eli Lilly and Co Novo Nordisk A/S Social issues
From CNBC.com News
Healthy Returns: What we know about the next round of Covid vaccines
Tags Novavax Inc Biotech and Pharmaceuticals Pfizer Inc
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags AstraZeneca PLC Health care industry Healthy Returns
From CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
Tags Pfizer Inc Biotech and Pharmaceuticals Johnson & Johnson
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Health care industry Healthy Returns Health & Science
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Biotech and Pharmaceuticals Social issues Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Novo Nordisk A/S Eli Lilly and Co Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Teva Pharmaceutical Industries Ltd Health & Science Abbvie Inc
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.